NEW YORK (MarketWatch) — The U.S. stocks were under pressure on Wednesday as crude-oil prices gave up part of the gains racked up over a four-day trading span, while a report on private-sector hiring disappointed.Private employers added 213,000 jobs in January, according Automatic Data Processing Inc. Economists use the number to get a feel for the official jobs report due […]
Biotech companies are restoring sight to the blind, curing hepatitis C and fighting off HIV.As they save lives, biotech companies are simultaneously making a lot of money for investors.That’s why the hottest ETFs (exchange-traded funds) on the planet since the bull market began in March 2009 invest in biotech companies.The First Trust NYSE Arca Biotech ETF (FBT) has skyrocketed more […]
View gallery.This article is written by Christian Tharp, the author of 5 Star Trading.The S&P 500 hit its last all-time high back at the end of 2014, and has chopped lower since.The Nasdaq has fared a bit better over that stretch, but the index still has yet to hit a new bull market high since the end of December.Through this period […]
When it comes to figuring out the best stocks to buy in any given month or year, crystal balls can be hazy, but our top Motley Fool contributors have scoured SEC filings, read industry trade journals, and crunched numbers to uncover three biotech stocks that they think could be among the top stocks to buy in February.Source: BioMarin.: The road […]
Although biotech stocks as a whole handily outpaced the S&P 500 returns last year, there’s no guarantee that investors will be similarly rewarded this year. To get insight into whether biotech stocks can continue climbing, we asked three top Motley Fool contributors to give us their opinion. Read on to learn what they think.: Bringing a new drug to market […]
Source: Flickr user stockmonkeys.com .The pop-and-drop nature of the biotech industry makes owning stocks in the sector particularly dicey. But for investors willing to take on the risk of failure, a number of intriguing small-cap biotech companies are working on important new therapies that could make a big impact on patients’ lives and investors’ wallets. Here are three of thesecompanies.No. […]
It’s been shown that dividend-paying stocks outperform their non-dividend paying counterparts, but focusing on dividends may not be the best strategy when it comes to big biotech stocks. Read on to learn why three Motley Fool contributors don’t think it makes sense for these big biotech companies to pay investors a dividend.Cheryl Swanson : Take a little trip through history […]
A survey of investable Canadian sectors will eventually lead back to biotechnology, a corner of the market sure to elicit some well-deserved skepticism.With U.S. biotech stocks setting a torrid pace over the last several years, some of the hype was bound to spread to Canada, which has seen a recent uptick in biotech listings.More Related to this Story
Under fire, marijuana […]
LONDON, January 28, 2015 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Halozyme Therapeutics Inc. (NASDAQ: HALO), Agenus Inc. (NASDAQ: AGEN), Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research report on Halozyme Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Halozyme%20Therapeutics&d=28-Jan-2015&s=HALO. On Tuesday, January 27, 2015, the NASDAQ Composite ended at 4,681.50, […]
